Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6220)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 18, 2023 (publication date) through Dec 26, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Transplantation
ISSN
2220-3230
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Diamond A, Karhadkar S, Chavin K, Constantinescu S, Lau KN, Perez-Leal O, Mohrien K, Sifontis N, Di Carlo A. Dosing strategies for de novo once-daily extended release tacrolimus in kidney transplant recipients based on CYP3A5 genotype. World J Transplant 2023; 13(6): 368-378 [PMID: 38174147 DOI: 10.5500/wjt.v13.i6.368] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Diamond A, Karhadkar S, Chavin K, Constantinescu S, Lau KN, Perez-Leal O, Mohrien K, Sifontis N, Di Carlo A. Dosing strategies for de novo once-daily extended release tacrolimus in kidney transplant recipients based on CYP3A5 genotype. World J Transplant 2023; 13(6): 368-378 [PMID: 38174147 DOI: 10.5500/wjt.v13.i6.368] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v13/i6/368.htm |
| Number | Citing Articles |
| 1 |
Anna Vidal-Alabró, Pere Fontova, Zeyar Mohammed Ali, Beatriz Fernández-Alarcón, Gema Cerezo, Edoardo Melilli, Nuria Montero, Ana Coloma, Anna Manonelles, Alexandre Favà, Sergi Codina, Carlos Couceiro, Laia Oliveras, Joan Torras, Josep M. Grinyó, Josep M. Cruzado, Helena Colom, Nuria Lloberas. Tacrolimus Conversion in CYP3A5*1 Expressers: From Immediate-Release to LCP Formulation. Therapeutic Drug Monitoring 2025; doi: 10.1097/FTD.0000000000001411
|